NTL Healthcare, a company specialized in women's cancer, unveiled the CerviCARE AI, artificial intelligence (AI) cervical cancer screening system,

at the Medical Fair India (MFI) held from March 13 to 15, receiving warm responses from Indian medical professionals and stakeholders.

 

The visitors from a total of 32 countries, around 9,000 people, attended the successful conclusion of the medical device exhibition in India.

Participants, who were aware of Korea's high medical service system, expressed a consensus on the necessity of the CerviCARE AI,

which can quickly and accurately screen cancer using AI, especially in India, which is vulnerable to cervical cancer.

 

According to WHO data, India has the second highest mortality rate from cervical cancer, with over 120 deaths daily.

However, due to geographical conditions and poor early screening systems, only one in ten Indian women undergo cervical cancer screening.

 

Indian medical professionals believe that the CerviCARE AI can contribute significantly to reducing cervical cancer in India

by enabling rapid and accurate on-site screening. They express hope that the system will be able to be quickly supplied throughout India,

especially in remote rural areas where telemedicine systems are feasible.

 

NTL Healthcare has stated that the CerviCARE AI, which has attracted keen interest from over 200 companies including India,

aims to be distributed nationwide within the year and is currently in the process of signing contracts with medical organizations

including the Indian health authorities, with the goal of expanding access to the technology across India.